BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16445351)

  • 1. Discovery of regulatory molecular events and biomarkers using 2D capillary chromatography and mass spectrometry.
    Powell DW; Merchant ML; Link AJ
    Expert Rev Proteomics; 2006 Feb; 3(1):63-74. PubMed ID: 16445351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of quantitative mass spectrometry analysis in kidney research.
    Cummins TD; Powell DW
    Semin Nephrol; 2007 Nov; 27(6):574-83. PubMed ID: 18061840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational methods for the comparative quantification of proteins in label-free LCn-MS experiments.
    Wong JW; Sullivan MJ; Cagney G
    Brief Bioinform; 2008 Mar; 9(2):156-65. PubMed ID: 17905794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput analysis of protein/peptide complexes by immunoprecipitation and automated LC-MS/MS.
    Lin Z; Crockett DK; Lim MS; Elenitoba-Johnson KS
    J Biomol Tech; 2003 Jun; 14(2):149-55. PubMed ID: 14676314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of high-grade dysplastic cervical cells obtained from ThinPrep slides using laser capture microdissection and mass spectrometry.
    Gu Y; Wu SL; Meyer JL; Hancock WS; Burg LJ; Linder J; Hanlon DW; Karger BL
    J Proteome Res; 2007 Nov; 6(11):4256-68. PubMed ID: 17902640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of LC/MS to proteomics studies: current status and future prospects.
    Chen G; Pramanik BN
    Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in computational analysis of mass spectrometry for proteomic profiling.
    Sun CS; Markey MK
    J Mass Spectrom; 2011 May; 46(5):443-56. PubMed ID: 21500303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment.
    Dakna M; He Z; Yu WC; Mischak H; Kolch W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1250-8. PubMed ID: 19010091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers.
    Ackermann BL; Berna MJ
    Expert Rev Proteomics; 2007 Apr; 4(2):175-86. PubMed ID: 17425454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS/MS based proteomic analysis and functional inference of hypothetical proteins in Desulfovibrio vulgaris.
    Zhang W; Culley DE; Gritsenko MA; Moore RJ; Nie L; Scholten JC; Petritis K; Strittmatter EF; Camp DG; Smith RD; Brockman FJ
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1412-9. PubMed ID: 16982031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
    Schiffer E; Mischak H; Novak J
    Proteomics; 2006 Oct; 6(20):5615-27. PubMed ID: 16991199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis.
    Boehmer JL; DeGrasse JA; McFarland MA; Tall EA; Shefcheck KJ; Ward JL; Bannerman DD
    Vet Immunol Immunopathol; 2010 Dec; 138(4):252-66. PubMed ID: 21067814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic identification of salivary biomarkers of type-2 diabetes.
    Rao PV; Reddy AP; Lu X; Dasari S; Krishnaprasad A; Biggs E; Roberts CT; Nagalla SR
    J Proteome Res; 2009 Jan; 8(1):239-45. PubMed ID: 19118452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alignment of LC-MS images, with applications to biomarker discovery and protein identification.
    Vandenbogaert M; Li-Thiao-Té S; Kaltenbach HM; Zhang R; Aittokallio T; Schwikowski B
    Proteomics; 2008 Feb; 8(4):650-72. PubMed ID: 18297649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis.
    Govorukhina NI; Reijmers TH; Nyangoma SO; van der Zee AG; Jansen RC; Bischoff R
    J Chromatogr A; 2006 Jul; 1120(1-2):142-50. PubMed ID: 16574134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.